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Dear Editors,
A ventricular septal defect (VSD) is one or more holes in
the wall that separates the right and left ventricles of the
heart. VSD is one of the most common congenital (present
from birth) heart defects. Many types of VSDs have been
reported, including congenital VSDs, post-infarction VSDs
(1), and post-traumatic VSDs (2). Furthermore, there are
four types of congenital VSDs; perimembranous VSD is the
most common, while outlet, atrioventricular, and muscular
VSDs are less common (3). VSDs vary in size, number, and
location within the interventricular septum, and their
clinical implications often depend on these factors.
Childhood mortality has continuously decreased in recent
decades, and mortality has shifted almost entirely to
adulthood as a result of both conservative and surgical
treatments (4). Small congenital VSDs often close on their
own as the heart grows, and such patients may be treated
conservatively (5). However, some patients may require
surgical intervention. Percutaneous closure of VSDs has
emerged as a good alternative to address important and
difficult cardiac surgical problems and prevent issues
related to cardiopulmonary bypass in selected patients (2).
The most important issue prior to percutaneous closure is to
decide whether the defect can be closed via a percutaneous
approach and which device should be chosen.
Various devices that have been used for VSD closure have
been reported in previous articles. These devices include
amplatzerH VSD Occluder, atrial septal defect (ASD)
Occluder, and patent ductus arteriosus (PDA) Occluder
(2,6,7). However, there is no clear consensus on device
selection (8). The investigators present their experience with
choosing devices for percutaneous VSD closure in this paper.
The main factor in choosing a device is the length of the
occluder’s waist. The Amplatzer Muscular VSD Occluder and
ASD Occluder are designed for congenital heart disease, and
congenital VSDs are uniformly straight and short. Therefore, the
length of occluder’s waist is limited to approximately 4 mm.
This device is also suitable for post-infarction VSDs and other
straight and short VSDs (6,7). Post-traumatic VSDs, as described
by Xi EP, Zhu J, Zhu SB and their colleagues, are angled (2). The
length of this type of VSD is typically longer, frequently more
than 9 mm. Therefore, the Amplatzer Muscular VSD Occluder
and ASD Occluder are not appropriate.
The use of the PDA Occluder for post-traumatic VSD
closure suggested a new way of approaching treatment for
the closure of different types of VSDs and provided a new
standard for the design of occlusion devices. The use of the
PDA Occluder for VSD closure has several advantages
compared with the Amplatzer Muscular VSD Occluder and
the ASD Occluder. First, if the right-sided opening of the
VSD is near the right ventricular outflow tract, the right disc
may obstruct the ventricular outflow tract when VSD or
ASD Occluders are used. The PDA Occluder cannot cause
ventricular outflow tract obstruction because it only has a
left disc; furthermore, this single disc reduces the cost of the
closure device. In addition, the metal waist of a PDA
Occluder is both more flexible and softer than other
occluder implants, so it is more easily released and molded.
The implant also moves in synchrony with the heartbeat.
Fatigue damage to an occluder’s metal material (9) occurs
under the action of the dynamic load, and an implant’s main
cause of failure is fatigue rupture. This type of rupture is
more likely to occur in occluders that have two discs and a
very narrow waist, which are more likely to experience
fatigue rupture because of the loads on the two discs.
Based on our limited experience and a lower observed
morbidity rate, our view is detailed below. The use of PDA
Occluder devices for percutaneous closure of post-traumatic
VSDs is feasible, safe and effective. This method could allow all
types of VSDs to be closed via a percutaneous approach.
Furthermore, the use of a PDA Occluder provides a new
standard for the design of occluder devices. However, in the
absence of larger studies comparing surgical options, observa-
tional management and skillful clinical intervention, and most
clinicians have more clinical experience using these devices, we
suggest continuing to use a VSD Occluder or ASD Occluder in
general VSD cases for routine repair for a longer experience on
clinical application. But due to different types of VSD, different
options of the device should be taken to solve them.
& REFERENCES
1. Lee WY, Kim SJ, Kim KI, Lee JW, Kim HS, Lee HS, et al. Transatrial
repair of post-infarction posterior ventricular septal rupture.
Korean J Thorac Cardiovasc Surg. 2011;44(2):186-8.
2. Xi EP, Zhu J, Zhu SB, Yin GL, Liu Y, Dong YQ, et al. Percutaneous
closure of a post-traumatic ventricular septal defect with a patent ductus
Copyright  2014 CLINICS – This is an Open Access article distributed under
the terms of the Creative Commons Attribution Non-Commercial License (http://
creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-
commercial use, distribution, and reproduction in any medium, provided the
original work is properly cited.
No potential conflict of interest was reported.
DOI: 10.6061/clinics/2014(02)12
READERS OPINION
150
arteriosus occlude. Clinics. 2012;67(11):1281-3, doi: 10.6061/clinics/
2012(11)10.
3. Brickner ME, Hillis LD, Lange RA. Congenital heart disease in adults.
First of two parts. N Engl J Med. 2000;342(4):256-63.
4. Greutmann M, Tobler D. Changing epidemiology and mortality in adult
congenital heart disease: looking into the future. Future Cardiol. 2012;
8(2):171-7, doi: 10.2217/fca.12.6.
5. Sama´nek M. Children with congenital heart disease: probability of
natural survival. Pediatr. Cardiol. 1992;13(3):152-8.
6. Fraisse A, Agnoletti G, Bonhoeffer P, Aggoun Y, Benkhalifa A, Piechaud
JF. Multicentre study of percutaneous closure of interventricular
muscular defects with the aid of an Amplatzer duct occluder prosthesis.
Arch Mal Coeur Vaiss. 2004;97:484-8.
7. Suh WM, Kern MJ. Transcatheter closure of a traumatic VSD in an adult
requiring an ASD occluder device. Catheter Cardiovasc Interv. 2009;
74(7):1120-5, doi: 10.1002/ccd.22141.
8. Sait Demirkol, Sevket Balta, Mustafa Cakar, Ugur Kucuk. Which device
should be chosen for the percutaneous closure of post-traumatic
ventricular septal defects? Clinics. 2013;68(3):423.
9. Bafaloukas N, Birch M, Buchholz N. Rationale and feasibility study of a
mechanical model for the testing of material fatigue in metal ureteral
stents. J Endourol. 2008;22(2):389-92, doi: 10.1089/end.2006.9862.
CLINICS 2014;69(2):150-151 Device selection for VSD repair
Zhu J et al.
151
